Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Trypanosoma Cruzi (T. cruzi)
100%
Drug Discovery
85%
Visceral Leishmaniasis
67%
Chagas Disease
66%
Leishmania Donovani
49%
Trypanosoma Brucei
34%
Drug Target
34%
Anti-trypanosomatid Drugs
27%
Human African Trypanosomiasis
25%
Dundee
25%
Protease Inhibitors
23%
New Drugs
23%
Microbiology
20%
Mouse Model
19%
High-throughput Screening
18%
Nifurtimox
18%
Protozoan Parasites
17%
Infectious Diseases
17%
Preclinical Candidate
17%
Anti-infective
17%
Mode of Action
17%
Leishmania
17%
Current Treatment
16%
Benznidazole
16%
Wellcome
16%
Metabolic Stability
15%
High-throughput
14%
Screening Cascade
14%
Chagas Disease Drug Discovery
14%
Phenotypic Screening
13%
Methionyl-tRNA Synthetase
13%
Apologizing
13%
Pyrazolo
13%
Tankyrase
13%
Axenic
13%
High Content
13%
Cyclin-dependent Kinase 12
13%
Protein Kinase
13%
Training Participation
13%
Research Participation
13%
Research Training
13%
Public Engagement
13%
Cell-based
13%
Bile Duct Ligation
12%
In Vivo Efficacy
12%
Hit Discovery
12%
Biochemical Assay
12%
Cytochrome b
11%
Scaffold Hopping
11%
Cytocidal
11%
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
89%
Trypanosoma Cruzi
77%
Visceral Leishmaniasis
76%
Chagas Disease
75%
Diseases
47%
Trypanosoma Brucei
35%
Proteasome
31%
Leishmania donovani
27%
Proteasome Inhibitor
23%
African Trypanosomiasis
23%
Mouse Model
22%
Trypanosomatidae
22%
Protozoon
22%
Hexachlorophene
22%
Leishmania
20%
Pharmacokinetics
20%
Structure Activity Relationship
19%
Kinetoplastida
17%
Carboxamide
16%
Benznidazole
14%
Binding Site
14%
Methionine Transfer RNA Ligase
13%
Cyclin Dependent Kinase
13%
Tropical Disease
12%
Phosphotransferase
12%
High-Throughput Screening
12%
Nifurtimox
11%
Infection
11%
Cytochrome B
11%
Amastigote
11%
Clinical Trial
11%
Side Effect
10%
Adenosine Triphosphate
10%
Leishmania infantum
10%
Molecular Target
9%
Nitric Oxide
9%
Parasitosis
8%
Trypanosoma
8%
Repurposing
8%
Pharmaceutical Chemistry
8%
Lead Compound
8%
Lanosterol 14 Alpha-Demethylase
8%
Neglected Disease
8%
Leishmaniasis
7%
Piperazine Derivative
6%
Purinergic Receptor Stimulating Agent
6%
Target Identification
6%
Amitrole
6%
Pyrimidine Derivative
6%
2,5 Bis(4 Amidinophenyl)furan
6%
Immunology and Microbiology
Trypanosoma Cruzi
63%
Chagas Disease
48%
Leishmania donovani
46%
Visceral Leishmaniasis
42%
Proteasome
38%
Leishmania
26%
High Throughput Screening
21%
Trypanosoma Brucei
20%
Amastigote
18%
Kinetoplastida
17%
Axenic
17%
Intracellular Parasite
14%
Trypanosoma
13%
Cytochrome
13%
Transfer RNA
13%
Benznidazole
13%
Protozoa
12%
Leishmania infantum
10%
Leishmaniasis
9%
Binding Site
9%
Qi
9%
Trypanosomatid
9%
Trypomastigote
8%
Aortic Smooth Muscle Cell
6%
Bile Duct
6%
In Vitro
6%
Oligomerization
6%
Microorganism
6%
Enantiomer
6%
Leishmania chagasi
6%
Life Cycle
6%
Microbiology
6%
Kinetochore
6%
Solution and Solubility
6%
Codon
6%
Drug Binding Site
6%
Smooth Muscle Cell
6%
Cryo-Electron Microscopy
5%
Parasitic Disease
5%
Life Cycle Stage
5%
Mouse Model
5%
